Phosphatidylinositol 3 Kinase δ Inhibitors: Present and Future
This article reviews the clinical data on efficacy and toxicity across the class and discusses ongoing efforts to understand and mitigate the likely on-target autoimmune toxicity.
Source: The Cancer Journal - Category: Cancer & Oncology Tags: Review Articles Source Type: research
More News: Cancer | Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Leukemia | Toxicology